Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sharadashri Rao"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 03, Pp 32-35 (2024)
Introduction: Incorporating the concepts of hyperviscosity, platelet hyperactivity, and age-related risk of Acute Coronary Syndrome (ACS), a new score has been put forward-the Mean platelet volume-Age-total Protein-Haematocrit (MAPH) score, which can
Externí odkaz:
https://doaj.org/article/5f321b51ffe243c9aa987e566999d9b8
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 04, Pp 01-02 (2024)
Meropenem is a broad-spectrum antibacterial agent given empirically for diseases caused by single or multiple susceptible bacteria in both adults and children with a wide range of serious infections. Several studies have reported an association betwe
Externí odkaz:
https://doaj.org/article/72d9ba2173a34516983024eb54a27aff
Publikováno v:
Global Journal of Medicine and Public Health, Vol 12, Iss 4 (2024)
Drug utilization study is a powerful tool to evaluate the rational drug use practices by monitoring the prescribing pattern. The objective of this study was to evaluate the drug utilization pattern based on WHO core prescribing indicators in the E.N.
Externí odkaz:
https://doaj.org/article/bdf66d2078554ca49e894713aebfacb5
Autor:
Sharadashri Rao, P.V. Narayanan
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 1, Pp FC13-FC15 (2016)
Introduction: Timolol, a beta blocker, is the most commonly prescribed first line therapy in the treatment of primary open angle glaucoma. Latanoprost, a prostaglandin analogue, is a novel drug in glaucoma therapy. Its efficacy has to be proved for
Externí odkaz:
https://doaj.org/article/e066dfe2f7404447a260ded3ea3893c7
Autor:
Sharadashri Rao, P. V. Narayanan
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :966-969
Background: Topical beta blockers, Timolol and the prostaglandin F2α analogue Latanoprost are the most common prescribed medications as first line therapy. Their safety profiles have to be compared to justify the same. The objectives of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a13c852a75870098cdb07ec91d798976
https://doi.org/10.18203/2319-2003.ijbcp20150875
https://doi.org/10.18203/2319-2003.ijbcp20150875
Autor:
P.V. Narayanan, Sharadashri Rao
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 1, Pp FC13-FC15 (2016)
Introduction: Timolol, a beta blocker, is the most commonly prescribed first line therapy in the treatment of primary open angle glaucoma. Latanoprost, a prostaglandin analogue, is a novel drug in glaucoma therapy. Its efficacy has to be proved for i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f0b5a035ade82e8c5b8c61ca80529d4
https://jcdr.net/articles/PDF/7135/16923_CE(RA1)_F(T)_PF1(Vsu_Om)_PFA(AK)_PF2(PAG).pdf
https://jcdr.net/articles/PDF/7135/16923_CE(RA1)_F(T)_PF1(Vsu_Om)_PFA(AK)_PF2(PAG).pdf